An AllTrials project

NCT03355365: A trial that was reported late by Tisch Multiple Sclerosis Research Center of New York

This trial has reported, although it was 376 days late in doing so.

Full data

Full entry on ClinicalTrials.gov NCT03355365
Title Autologous, Bone Marrow-Derived Mesenchymal Stem Cell-Derived Neural Progenitor Cells (MSC-NP), Expanded Ex Vivo; Administered Intrathecally
Results Status Reported (late)
ACT or pACT? This is what FDAAA officially calls an "Applicable Clinical Trial"
Start date Sept. 21, 2018
Completion date Feb. 9, 2023
Required reporting date Feb. 9, 2024, midnight
Actual reporting date Feb. 19, 2025
Date last checked at ClinicalTrials.gov Aug. 12, 2025
Days late 376